Mirae Asset Global ETFs Holdings’s CervoMed CRVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,314
Closed -$30.3K 3056
2025
Q1
$30.3K Buy
3,314
+156
+5% +$594 ﹤0.01% 2926
2024
Q4
$7.39K Buy
3,158
+152
+5% +$1.48K ﹤0.01% 3036
2024
Q3
$43.9K Buy
+3,006
New +$46.6K ﹤0.01% 2942

Other funds holding CRVO

Mirae Asset Global ETFs Holdings's CRVO Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of CervoMed (CRVO) in Q2 2025, closing a stake of 3,314 shares — an estimated $30.3K sold.

Mirae Asset Global ETFs Holdings first reported a position in CRVO in Q3 2024 and held it in 3 quarters. The position peaked at $43.9K in Q3 2024. 45 funds tracked by Wall St. Rank hold CRVO as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining CervoMed position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 3,314 CervoMed shares in Q2 2025, an estimated $30.3K.
  • Mirae Asset Global ETFs Holdings first reported a position in CervoMed in Q3 2024 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's CervoMed position peaked at $43.9K in Q3 2024.
  • 45 funds tracked by Wall St. Rank held CervoMed as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.